Sort   by:  
 Page size 
UnknownEvidence-based appraisal of the upfront treatment for unresectable metastatic colorectal cancer patients.
Not available
S-EPMC3870493 | biostudies-literature
UnknownLow-Dose Oral Cyclophosphamide and Methotrexate Maintenance for Hormone Receptor-Negative Early Breast Cancer: International Breast Cancer Study Group Trial 22-00.
Not available
S-EPMC5035120 | biostudies-literature
UnknownAssociation of supratotal resection with progression-free survival, malignant transformation, and overall survival in lower-grade gliomas.
Not available
S-EPMC8099476 | biostudies-literature
UnknownAutoantibodies Specific to ERα are Involved in Tamoxifen Resistance in Hormone Receptor Positive Breast Cancer.
Not available
S-EPMC6678306 | biostudies-literature
UnknownComposite risk and benefit from adjuvant dose-dense chemotherapy in hormone receptor-positive breast cancer.
Not available
S-EPMC8238951 | biostudies-literature
UnknownDevelopment of a nomogram for predicting pathological complete response in luminal breast cancer patients following neoadjuvant chemotherapy.
Not available
S-EPMC10017935 | biostudies-literature
UnknownT-DM1 versus pertuzumab, trastuzumab and a taxane as first-line therapy of early-relapsed HER2-positive metastatic breast cancer: an Italian multicenter observational study.
Not available
S-EPMC8047485 | biostudies-literature
UnknownClinico-pathological predictors of radiologic complete response to first-line anti-HER2 therapy in metastatic breast cancer.
Not available
S-EPMC11655875 | biostudies-literature
UnknownFactors associated with first-to-second-line attrition among patients with metastatic breast cancer in the real world.
Not available
S-EPMC11794064 | biostudies-literature
UnknownSNP of Aromatase Predict Long-term Survival and Aromatase Inhibitor Toxicity in Patients with Early Breast Cancer: A Biomarker Analysis of the GIM4 and GIM5 Trials.
Not available
S-EPMC10722129 | biostudies-literature
Sort   by:  
 Page size